Weekly round-up #259
World TB Day 2023 - Yes we can #EndTB!
Friday, 24th March, is World TB Day, and as usual we encourage members of the VALIDATE network to get involved and make a difference in the fight against TB. The theme of this year's event, "Yes! We can end TB!", aims to inspire hope and promote leadership, investment, innovation, and collaboration to combat the TB epidemic. As vaccine researchers, members of VALIDATE can get involved by sharing their expertise and research on social media, raising awareness about TB, and advocating for increased funding for TB vaccine development. By working together, we can make progress towards ending TB and improving global health.
You can find more information about World TB Day and some social media materials on the WHO Website.
- UKRI cross research council responsive mode pilot scheme - Funding for interdisciplinary ideas that transcend, combine or significantly span disciplines - deadline TBA (June 2023)
- UKRI Future Leaders Fellowships - Round 8 - £900 million fund that is helping to establish the careers of world-class research and innovation leaders across UK business and academia - deadline 4 July 2023
- MRC Applied Global Health Partnership - Funding to develop an integrated research and innovation programme to deliver UK research capacity and capability - deadline TBA – (Mid July 2023)
You can find a list of all relevant external funding we've spotted for our members on our external funding page.
Training Opportunities and Events:
- World TB Day Symposium 2023, London, UK, 24 March 2023 - World TB Day
- The New York Academy of Sciences – Frontiers in Immunology Symposium, New York, USA - 11- 12 April 2023
- Director, Infection and Immunity Research Institute, St George's, University of London, UK, deadline 6 April 2023
- Research Fellow in Bioinformatics, University of Southampton, UK, deadline 17 April 2023
Other relevant career opportunities are on our jobs page.
-
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study, VALIDATE member Rebecca A Clark et al, in The Lancet Global Health
-
Evaluation of immunomodulatory potential of recombinant histidyl-tRNA synthetase (rLdHisRS) protein of Leishmania donovani as a vaccine candidate against visceral leishmaniasis, Kushwaha V et al, in Acta Tropica
-
Discovery of small molecule inhibitors of Mycobacterium tuberculosis ClpC1: SAR studies and antimycobacterial evaluation, Bhanot, A et al, in Results in Chemistry
Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.
Highlights on Twitter this week:
Members Alba Llibre Serradell and Gabrielle Pollara congratulated us on a successful #VALIDATE2023, VALIDATE member Rebecca Clarke published an article in Lancet: Global Health, and Nature discussed how cell-free processes could speed up vaccine development. The Irish Examiner reported on how a global shortage of BCG is impacting Limerick, Healio discussed the challenges for developing a second TB Vaccines with Frank Cobelens from University of Amsterdam, and Nature Careers shared 6 tips for emailing investigators. The British Society for Immunology are looking for PhD students to join their Member Representative Forum, Mueller Health shared an interview with a survivor of TB, and the NIH discussed research on a freeze dried TB Vaccine. Finally, PreFIT and the Stop TB Partnership marked World TB Day. Keep up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter.
Published: 22 March 2023
